SM

Shreya Maskara

Active Director Director DIN 10618893
DIN 10618893 First appointment Feb 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Shreya Maskara

Data last updated:

Shreya Maskara is a Director at Piyumedic Pharma Private Limited (since 2024). The company operates in Pharma. Piyumedic Pharma Private Limited reported revenue of ₹50,000 (FY 2025).

DIN 10618893
Primary Designation Director
Industry Pharma
First Appointment 29 Feb 2024
Oldest Company Age 5 yrs
Largest company Piyumedic Pharma Private Limited · ₹50,000 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Piyumedic Pharma Private Limited U24230OR2021PTC037311
Director29 Feb 20242021₹50,000 (FY 2025)Active

Board colleagues of Shreya Maskara

NameDINCompanyDesignation
Anupam Agarwal08396142Piyumedic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Piyumedic Pharma Private Limited
Premium access

Shareholding and investment profile for Shreya Maskara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreya Maskara

Shreya Maskara currently holds 1 directorship: Piyumedic Pharma Private Limited (Director, since 29 Feb 2024, revenue ₹50,000 (FY 2025)).

Shreya Maskara was first appointed on 29 Feb 2024 as Director at Piyumedic Pharma Private Limited.

The current boards of Shreya Maskara's companies include Anupam Agarwal (Piyumedic Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available